Patent Acquisition Intelligence
Make informed decisions before acquiring patent assets.
Patent Acquisition Intelligence & Due Diligence
Patent acquisition intelligence
Make informed decisions before acquiring patent assets.
IIPRD is a technical and strategic research partner that helps buyers evaluate patent assets, assess technology relevance, uncover potential risks and prioritize acquisition opportunities. We look beyond ownership to the question that matters: should you acquire these assets, and what do you need to understand before proceeding?
Look beyond patent ownership to understand asset potential
Purchasing patent assets without sufficient technical and commercial assessment exposes buyers to avoidable uncertainty. A structured review surfaces the issues that determine whether an asset is worth acquiring.
Unclear relevance to existing or emerging products and technologies.
Little insight into claim coverage, scope and competitive relevance.
Redundancy with existing assets and the presence of alternative technologies.
Remaining patent life and geographic limitations that affect value.
Uncertain licensing prospects and routes to commercial use.
IIPRD's assessment converts these uncertainties into decision-ready intelligence.
A multidimensional review of patent assets before investment
Six differentiated modules that together answer whether an asset is technically sound, commercially relevant and strategically aligned.
Patent Asset Screening
Identify candidate patents aligned with your acquisition objectives and qualify them for deeper review.
Technical Merit Assessment
Examine claim scope, technology coverage and implementation relevance to gauge asset quality.
Product-to-Patent Correlation
Map patent claims to relevant products, features and technologies, including Evidence of Use where in scope.
Competitive Positioning Analysis
Examine competing solutions, patent coverage and strategic differentiation around the target assets.
Portfolio Composition Review
Assess family structure, geographic coverage, remaining term and portfolio overlap.
Commercial Opportunity Assessment
Examine licensing pathways, market applications and strategic utility of the assets.
From patent screening to acquisition prioritization
A six-stage assessment framework that moves from acquisition objectives to a ranked, decision-ready shortlist.
Acquisition objectives
Define technology priorities, target markets and transaction requirements.
Asset identification
Organize candidate patents into families and relevant technology groups.
Technical examination
Review claims, specifications, patent status and relevant prosecution records.
Market and product correlation
Identify relevant products, applications, competitors and potential users.
Opportunity and risk screening
Highlight technical limitations, competitive overlap and commercial uncertainties.
Acquisition prioritization
Rank assets against agreed criteria and present findings for decision-making.
Decision-ready intelligence for your acquisition team
Outputs are available depending on scope, procurement-friendly and built to support an investment decision.
Asset-level technical and commercial findings.
Evidence of Use linking claims to products and features.
Patent families and jurisdictional coverage at a glance.
Structured view of limitations and uncertainties.
Side-by-side scoring across agreed criteria.
Ranked shortlists of high-priority candidates.
Condensed conclusions for decision-makers.
Consolidated package drawing the deliverables together.
Supporting strategic, financial and technology-led transactions
Different buyers arrive with different objectives. The assessment is scoped to the transaction in front of you.
Strategic portfolio strengthening
Targeted purchases that reinforce an existing portfolio.
Technology-driven M&A
Technology-led mergers and acquisitions.
Operating-company purchases
Portfolio purchases from operating companies.
Startup and research IP
Asset purchases from startups or research institutions.
Licensing-oriented acquisitions
Acquisitions aimed at licensing and monetization.
Defensive acquisitions
Defensive purchases and competitive positioning.
Investment screening
Screening of patent-rich businesses for investors.
Cross-border transactions
Multi-jurisdictional deals needing coordinated review.
Cross-technology expertise for complex IP transactions
Patent and engineering expertise across the domains where high-value patent assets concentrate.
Telecommunications & SEPs
Semiconductors
AI & software
Connected devices
Automotive technologies
Medical devices
Energy systems
Industrial engineering
Technical depth. Commercial perspective. Actionable intelligence.
Capability converted into reasons to choose IIPRD for patent acquisition assessment.
Technical patent expertise
Patent and engineering specialists who read claims the way the technology works.
Structured evaluation
A repeatable framework from objectives to prioritized shortlist.
Product-level claim mapping
Claims mapped to real products, features and Evidence of Use.
Multi-jurisdictional research
Coverage across the jurisdictions relevant to the transaction.
Scalable portfolio screening
From a handful of assets to portfolios of thousands.
Licensing and commercialization link
Integrated with IIPRD's licensing and monetization support.
Turning a patent portfolio into a prioritized acquisition opportunity
An illustrative, clearly labelled scenario showing how the framework supports a real decision.
A buyer evaluating a broad portfolio of several hundred patents engages IIPRD to identify the assets worth acquiring. Screening organizes the patents into families and technology groups and sets them against the buyer's acquisition objectives. Technical examination then assesses claim scope and status, while product and market correlation maps the strongest claims to relevant products and competitors. Opportunity and risk screening flags limited remaining term, competitive overlap and commercialization uncertainty. The engagement closes with a ranked shortlist of high-priority acquisition candidates and an executive summary that the buyer's team can act on. Figures and assets here are illustrative and do not represent a specific transaction.
Frequently asked questions
1. What is patent acquisition intelligence and due diligence?
Patent acquisition intelligence is a structured technical and commercial assessment of patent assets a buyer is considering acquiring. It evaluates technology relevance, claim coverage, portfolio composition and commercialization potential, and prioritizes candidates so that acquisition decisions rest on decision-ready intelligence rather than ownership data alone.
2. How is this different from legal due diligence?
Legal due diligence typically focuses on ownership, chain of title, encumbrances, legal status and litigation history. Our assessment is primarily technical and commercial: it examines claim scope, product applicability, competitive positioning and strategic relevance. The two are complementary, and our findings can inform and sit alongside legal due diligence conducted by counsel.
3. How do you screen and qualify candidate patents?
Screening begins from your acquisition objectives, target technologies and markets. Candidate patents are organized into families and technology groups, then qualified against agreed criteria such as claim relevance, technical merit, remaining term and jurisdictional coverage to identify the assets that warrant deeper review.
4. What evaluation criteria do you apply?
Criteria are agreed with you at the outset and typically include technical merit and claim scope, product and market applicability, competitive overlap, portfolio fit, remaining patent life, geographic coverage and commercialization potential. Assets are then scored consistently so they can be compared on a like-for-like basis.
5. Do you provide Evidence of Use and claim-to-product mapping?
Yes, where it is within the agreed scope. Product-to-patent correlation maps individual claim limitations to relevant products, features and technologies, and can be developed into Evidence of Use charts that show how claims may read on real implementations.
6. What deliverables will we receive?
Depending on scope, deliverables can include patent-by-patent assessment reports, claim-to-product mapping and EoU charts, family and geographic coverage summaries, technical and commercial risk matrices, comparative scorecards, prioritized candidate lists, an executive summary and a consolidated acquisition assessment dossier.
7. How long does an acquisition assessment take?
Timelines depend on the number of patents, the depth of analysis and the technologies involved. A focused review of a small set of assets can be completed quickly, while a full portfolio screening with detailed claim mapping takes longer. A project-specific timeline is agreed after scoping.
8. What geographic and jurisdictional coverage do you offer?
We work across the jurisdictions relevant to the target assets and the intended transaction, reviewing patent families and geographic coverage so that remaining term and territorial limitations are clear before a decision is made.
9. Do you assess remaining patent term and legal status?
Yes. Portfolio composition review examines family structure, remaining term and relevant patent status as part of the assessment. Where formal legal opinions are required, these are provided by or in coordination with qualified counsel.
10. Do you provide patent valuation?
Our focus is technical and commercial relevance and acquisition prioritization rather than a formal monetary valuation. Our findings can feed into a valuation exercise, and IIPRD can support IP valuation separately where a monetary figure is required.
11. Can you screen large portfolios of hundreds or thousands of patents?
Yes. Portfolio-scale work is structured into broad screening followed by detailed assessment of prioritized assets. The sampling approach, depth and deliverables are agreed based on portfolio size and complexity so that effort is concentrated on the assets that matter most.
12. Which technology domains can you evaluate?
We cover telecommunications and SEPs, semiconductors, AI and software, connected devices, automotive technologies, medical devices, energy systems and industrial engineering, among other areas, drawing on patent and engineering expertise relevant to the assets under review.
13. Can you support M&A and investment screening?
Yes. The service supports strategic portfolio purchases, technology-driven mergers and acquisitions, licensing-oriented and defensive acquisitions, and investment screening involving patent-rich businesses, with the assessment scoped to the transaction type.
14. How is confidentiality handled?
Engagements can be structured around your confidentiality requirements, including non-disclosure agreements, secure document exchange and controlled handling of sensitive deal information throughout the assessment.
15. What engagement models do you offer, and how do we start?
Engagements can be scoped as a fixed-scope assessment, a phased screening-then-deep-dive programme or an ongoing support arrangement. To begin, share a patent portfolio, a list of target assets or an acquisition brief, and we will propose an appropriate scope, deliverables and timeline.